Analyzing pathway design from drug perturbation experiments

Noah Berlow, Ranadip Pal, Lara Davis, Charles Keller

Research output: Chapter in Book/Report/Conference proceedingConference contribution

4 Citations (Scopus)

Abstract

Drugs that target specific kinases are becoming common in cancer research. In this article, we analyze the design of a modeling approach for drug sensitivity prediction and combination targeted therapy design based on drug perturbation experiments. We consider a target inhibition map model that predicts the tumor sensitivities for all possible combination of target inhibitions. The estimation of the model is based on experimental sensitivity data for multiple target inhibitory drugs. The target inhibition map model provides a steady-state snapshot of the underlying dynamical model. To analyze the robustness of the combination therapy design approach, we consider the inverse problem of possible dynamic models that can generate the target inhibition map model and their transient and steady state response to drugs. We showed that the knowledge of the steady state target inhibition map can be used to estimate the directional pathway using a small number of steady state target expression measurements.

Original languageEnglish (US)
Title of host publication2012 IEEE Statistical Signal Processing Workshop, SSP 2012
Pages552-555
Number of pages4
DOIs
StatePublished - 2012
Event2012 IEEE Statistical Signal Processing Workshop, SSP 2012 - Ann Arbor, MI, United States
Duration: Aug 5 2012Aug 8 2012

Other

Other2012 IEEE Statistical Signal Processing Workshop, SSP 2012
CountryUnited States
CityAnn Arbor, MI
Period8/5/128/8/12

Fingerprint

Experiments
Inverse problems
Tumors
Dynamic models

ASJC Scopus subject areas

  • Signal Processing

Cite this

Berlow, N., Pal, R., Davis, L., & Keller, C. (2012). Analyzing pathway design from drug perturbation experiments. In 2012 IEEE Statistical Signal Processing Workshop, SSP 2012 (pp. 552-555). [6319757] https://doi.org/10.1109/SSP.2012.6319757

Analyzing pathway design from drug perturbation experiments. / Berlow, Noah; Pal, Ranadip; Davis, Lara; Keller, Charles.

2012 IEEE Statistical Signal Processing Workshop, SSP 2012. 2012. p. 552-555 6319757.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Berlow, N, Pal, R, Davis, L & Keller, C 2012, Analyzing pathway design from drug perturbation experiments. in 2012 IEEE Statistical Signal Processing Workshop, SSP 2012., 6319757, pp. 552-555, 2012 IEEE Statistical Signal Processing Workshop, SSP 2012, Ann Arbor, MI, United States, 8/5/12. https://doi.org/10.1109/SSP.2012.6319757
Berlow N, Pal R, Davis L, Keller C. Analyzing pathway design from drug perturbation experiments. In 2012 IEEE Statistical Signal Processing Workshop, SSP 2012. 2012. p. 552-555. 6319757 https://doi.org/10.1109/SSP.2012.6319757
Berlow, Noah ; Pal, Ranadip ; Davis, Lara ; Keller, Charles. / Analyzing pathway design from drug perturbation experiments. 2012 IEEE Statistical Signal Processing Workshop, SSP 2012. 2012. pp. 552-555
@inproceedings{2d0409c18bad4e088734dd712a0b7811,
title = "Analyzing pathway design from drug perturbation experiments",
abstract = "Drugs that target specific kinases are becoming common in cancer research. In this article, we analyze the design of a modeling approach for drug sensitivity prediction and combination targeted therapy design based on drug perturbation experiments. We consider a target inhibition map model that predicts the tumor sensitivities for all possible combination of target inhibitions. The estimation of the model is based on experimental sensitivity data for multiple target inhibitory drugs. The target inhibition map model provides a steady-state snapshot of the underlying dynamical model. To analyze the robustness of the combination therapy design approach, we consider the inverse problem of possible dynamic models that can generate the target inhibition map model and their transient and steady state response to drugs. We showed that the knowledge of the steady state target inhibition map can be used to estimate the directional pathway using a small number of steady state target expression measurements.",
author = "Noah Berlow and Ranadip Pal and Lara Davis and Charles Keller",
year = "2012",
doi = "10.1109/SSP.2012.6319757",
language = "English (US)",
isbn = "9781467301831",
pages = "552--555",
booktitle = "2012 IEEE Statistical Signal Processing Workshop, SSP 2012",

}

TY - GEN

T1 - Analyzing pathway design from drug perturbation experiments

AU - Berlow, Noah

AU - Pal, Ranadip

AU - Davis, Lara

AU - Keller, Charles

PY - 2012

Y1 - 2012

N2 - Drugs that target specific kinases are becoming common in cancer research. In this article, we analyze the design of a modeling approach for drug sensitivity prediction and combination targeted therapy design based on drug perturbation experiments. We consider a target inhibition map model that predicts the tumor sensitivities for all possible combination of target inhibitions. The estimation of the model is based on experimental sensitivity data for multiple target inhibitory drugs. The target inhibition map model provides a steady-state snapshot of the underlying dynamical model. To analyze the robustness of the combination therapy design approach, we consider the inverse problem of possible dynamic models that can generate the target inhibition map model and their transient and steady state response to drugs. We showed that the knowledge of the steady state target inhibition map can be used to estimate the directional pathway using a small number of steady state target expression measurements.

AB - Drugs that target specific kinases are becoming common in cancer research. In this article, we analyze the design of a modeling approach for drug sensitivity prediction and combination targeted therapy design based on drug perturbation experiments. We consider a target inhibition map model that predicts the tumor sensitivities for all possible combination of target inhibitions. The estimation of the model is based on experimental sensitivity data for multiple target inhibitory drugs. The target inhibition map model provides a steady-state snapshot of the underlying dynamical model. To analyze the robustness of the combination therapy design approach, we consider the inverse problem of possible dynamic models that can generate the target inhibition map model and their transient and steady state response to drugs. We showed that the knowledge of the steady state target inhibition map can be used to estimate the directional pathway using a small number of steady state target expression measurements.

UR - http://www.scopus.com/inward/record.url?scp=84868238241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868238241&partnerID=8YFLogxK

U2 - 10.1109/SSP.2012.6319757

DO - 10.1109/SSP.2012.6319757

M3 - Conference contribution

AN - SCOPUS:84868238241

SN - 9781467301831

SP - 552

EP - 555

BT - 2012 IEEE Statistical Signal Processing Workshop, SSP 2012

ER -